Literature DB >> 11134321

Recombinant expression of lymphocytic choriomeningitis virus strain WE glycoproteins: a single amino acid makes the difference.

W R Beyer1, H Miletic, W Ostertag, D von Laer.   

Abstract

Cytoplasmic vector systems are generally used for expression of lymphocytic choriomeningitis virus (LCMV) proteins. However, we achieved high levels of cell surface glycoproteins using a standard nuclear expression plasmid. Expression was independent of other LCMV proteins but was blocked by a missense mutation within the original LCMV(WE) glycoprotein cDNA.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11134321      PMCID： PMC114004          DOI： 10.1128/JVI.75.2.1061-1064.2001

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  19 in total

1.  Vaccination for disease.

Authors:  S Oehen; H Hengartner; R M Zinkernagel
Journal:  Science       Date:  1991-01-11       Impact factor: 47.728

2.  Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein.

Authors:  M Hany; S Oehen; M Schulz; H Hengartner; M Mackett; D H Bishop; H Overton; R M Zinkernagel
Journal:  Eur J Immunol       Date:  1989-03       Impact factor: 5.532

3.  Molecular characterization of the genomic S RNA segment from lymphocytic choriomeningitis virus.

Authors:  P J Southern; M K Singh; Y Riviere; D R Jacoby; M J Buchmeier; M B Oldstone
Journal:  Virology       Date:  1987-03       Impact factor: 3.616

4.  Lymphocytic choriomeningitis virus. VI. Isolation of a glycoprotein mediating neutralization.

Authors:  M Bruns; J Cihak; G Müller; F Lehmann-Grube
Journal:  Virology       Date:  1983-10-15       Impact factor: 3.616

5.  Induction of diabetes is influenced by the infectious virus and local expression of MHC class I and tumor necrosis factor-alpha.

Authors:  P S Ohashi; S Oehen; P Aichele; H Pircher; B Odermatt; P Herrera; Y Higuchi; K Buerki; H Hengartner; R M Zinkernagel
Journal:  J Immunol       Date:  1993-06-01       Impact factor: 5.422

6.  Complete sequence of the S RNA of lymphocytic choriomeningitis virus (WE strain) compared to that of Pichinde arenavirus.

Authors:  V Romanowski; Y Matsuura; D H Bishop
Journal:  Virus Res       Date:  1985-09       Impact factor: 3.303

7.  Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice.

Authors:  P S Ohashi; S Oehen; K Buerki; H Pircher; C T Ohashi; B Odermatt; B Malissen; R M Zinkernagel; H Hengartner
Journal:  Cell       Date:  1991-04-19       Impact factor: 41.582

8.  Protein-protein interactions in lymphocytic choriomeningitis virus.

Authors:  J W Burns; M J Buchmeier
Journal:  Virology       Date:  1991-08       Impact factor: 3.616

9.  Virus-lymphocyte interactions. IV. Molecular characterization of LCMV Armstrong (CTL+) small genomic segment and that of its variant, Clone 13 (CTL-).

Authors:  M Salvato; E Shimomaye; P Southern; M B Oldstone
Journal:  Virology       Date:  1988-06       Impact factor: 3.616

10.  Mice expressing both B7-1 and viral glycoprotein on pancreatic beta cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T-lymphocyte unresponsiveness.

Authors:  D M Harlan; H Hengartner; M L Huang; Y H Kang; R Abe; R W Moreadith; H Pircher; G S Gray; P S Ohashi; G J Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205
View more
  18 in total

1.  Identification of the lymphocytic choriomeningitis virus (LCMV) proteins required to rescue LCMV RNA analogs into LCMV-like particles.

Authors:  Ki Jeong Lee; Mar Perez; Daniel D Pinschewer; Juan Carlos de la Torre
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

2.  Endoproteolytic processing of the lymphocytic choriomeningitis virus glycoprotein by the subtilase SKI-1/S1P.

Authors:  Winfried R Beyer; Dennis Pöpplau; Wolfgang Garten; Dorothee von Laer; Oliver Lenz
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

3.  X-ray structure of the arenavirus glycoprotein GP2 in its postfusion hairpin conformation.

Authors:  Sébastien Igonet; Marie-Christine Vaney; Clemens Vonrhein; Clemens Vonhrein; Gérard Bricogne; Enrico A Stura; Hans Hengartner; Bruno Eschli; Félix A Rey
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-28       Impact factor: 11.205

4.  Identification of an N-terminal trimeric coiled-coil core within arenavirus glycoprotein 2 permits assignment to class I viral fusion proteins.

Authors:  Bruno Eschli; Katharina Quirin; Alexander Wepf; Jacqueline Weber; Rolf Zinkernagel; Hans Hengartner
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

5.  A-to-G hypermutation in the genome of lymphocytic choriomeningitis virus.

Authors:  Roland C Zahn; Ina Schelp; Olaf Utermöhlen; Dorothee von Laer
Journal:  J Virol       Date:  2006-10-04       Impact factor: 5.103

6.  Pseudotyping vesicular stomatitis virus with lymphocytic choriomeningitis virus glycoproteins enhances infectivity for glioma cells and minimizes neurotropism.

Authors:  Alexander Muik; Inna Kneiske; Marina Werbizki; Doris Wilflingseder; Tsanan Giroglou; Oliver Ebert; Anna Kraft; Ursula Dietrich; Gert Zimmer; Stefan Momma; Dorothee von Laer
Journal:  J Virol       Date:  2011-03-30       Impact factor: 5.103

7.  A specific interaction of small molecule entry inhibitors with the envelope glycoprotein complex of the Junín hemorrhagic fever arenavirus.

Authors:  Celestine J Thomas; Hedi E Casquilho-Gray; Joanne York; Dianne L DeCamp; Dongcheng Dai; Erin B Petrilli; Dale L Boger; Richard A Slayden; Sean M Amberg; Stephen R Sprang; Jack H Nunberg
Journal:  J Biol Chem       Date:  2010-12-15       Impact factor: 5.157

8.  Signal peptide requirements for lymphocytic choriomeningitis virus glycoprotein C maturation and virus infectivity.

Authors:  Sabrina Schrempf; Marc Froeschke; Tsanan Giroglou; Dorothee von Laer; Bernhard Dobberstein
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

9.  Molecular characterization of the genes coding for glycoprotein and L protein of lymphocytic choriomeningitis virus strain MX.

Authors:  Jana Tomaskova; Martina Labudova; Juraj Kopacek; Silvia Pastorekova; Jaromir Pastorek
Journal:  Virus Genes       Date:  2008-05-21       Impact factor: 2.332

10.  Remission of invasive, cancer stem-like glioblastoma xenografts using lentiviral vector-mediated suicide gene therapy.

Authors:  Peter C Huszthy; Tsanan Giroglou; Oleg Tsinkalovsky; Philipp Euskirchen; Kai Ove Skaftnesmo; Rolf Bjerkvig; Dorothee von Laer; Hrvoje Miletic
Journal:  PLoS One       Date:  2009-07-20       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.